Pegasus Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pegasus Asset Management's BMY Position: Q2 2023 in Review
Pegasus Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 28,083 shares — an estimated $1.95M sold.
Pegasus Asset Management first reported a position in BMY in Q4 2017 and held it in 22 quarters. The position peaked at $2.15M in Q2 2022. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Pegasus Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
- Pegasus Asset Management sold 28,083 Bristol-Myers Squibb shares in Q2 2023, an estimated $1.95M.
- Pegasus Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 22 quarters.
- Pegasus Asset Management's Bristol-Myers Squibb position peaked at $2.15M in Q2 2022.
- 2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Pegasus Asset Management's 13F filing for Q2 2023, filed 1 Aug 2023.